These peptides exhibit exquisite subtype selectivity and have been essential in characterizing native nAChR isoforms involved in neurotransmitter release modulation, Parkinson disease pathophysiology, and nociception [72]. The gene discussed is CHRNA4; the disease is Parkinson disease.